nodes	percent_of_prediction	percent_of_DWPC	metapath
Regorafenib—ABCG2—Glyburide—gestational diabetes	0.247	0.417	CbGbCtD
Regorafenib—CYP2C19—Glyburide—gestational diabetes	0.11	0.187	CbGbCtD
Regorafenib—CYP2C9—Glyburide—gestational diabetes	0.0918	0.155	CbGbCtD
Regorafenib—ABCB1—Glyburide—gestational diabetes	0.0891	0.151	CbGbCtD
Regorafenib—CYP3A4—Glyburide—gestational diabetes	0.0534	0.0902	CbGbCtD
Regorafenib—FLT1—umbilical vein—gestational diabetes	0.0133	0.062	CbGeAlD
Regorafenib—KDR—umbilical vein—gestational diabetes	0.0113	0.0524	CbGeAlD
Regorafenib—DDR2—uterus—gestational diabetes	0.00495	0.023	CbGeAlD
Regorafenib—DDR2—adipose tissue—gestational diabetes	0.00484	0.0225	CbGeAlD
Regorafenib—MAPK11—adipose tissue—gestational diabetes	0.00459	0.0213	CbGeAlD
Regorafenib—FLT4—embryo—gestational diabetes	0.00447	0.0208	CbGeAlD
Regorafenib—DDR2—vagina—gestational diabetes	0.00403	0.0187	CbGeAlD
Regorafenib—RET—embryo—gestational diabetes	0.00395	0.0184	CbGeAlD
Regorafenib—EPHA2—islet of Langerhans—gestational diabetes	0.00381	0.0177	CbGeAlD
Regorafenib—FGFR2—embryo—gestational diabetes	0.00375	0.0174	CbGeAlD
Regorafenib—DDR2—head—gestational diabetes	0.00372	0.0173	CbGeAlD
Regorafenib—TEK—embryo—gestational diabetes	0.0036	0.0167	CbGeAlD
Regorafenib—FLT1—islet of Langerhans—gestational diabetes	0.0036	0.0167	CbGeAlD
Regorafenib—RAF1—islet of Langerhans—gestational diabetes	0.00358	0.0166	CbGeAlD
Regorafenib—MAPK11—head—gestational diabetes	0.00353	0.0164	CbGeAlD
Regorafenib—BRAF—uterus—gestational diabetes	0.0035	0.0163	CbGeAlD
Regorafenib—FLT1—embryo—gestational diabetes	0.00348	0.0162	CbGeAlD
Regorafenib—RAF1—embryo—gestational diabetes	0.00346	0.0161	CbGeAlD
Regorafenib—BRAF—adipose tissue—gestational diabetes	0.00342	0.0159	CbGeAlD
Regorafenib—EPHX2—uterus—gestational diabetes	0.00334	0.0156	CbGeAlD
Regorafenib—EPHX2—adipose tissue—gestational diabetes	0.00327	0.0152	CbGeAlD
Regorafenib—PDGFRA—embryo—gestational diabetes	0.00326	0.0152	CbGeAlD
Regorafenib—FGFR1—uterus—gestational diabetes	0.00298	0.0138	CbGeAlD
Regorafenib—FLT4—adipose tissue—gestational diabetes	0.00295	0.0137	CbGeAlD
Regorafenib—KDR—embryo—gestational diabetes	0.00294	0.0137	CbGeAlD
Regorafenib—FGFR1—adipose tissue—gestational diabetes	0.00291	0.0135	CbGeAlD
Regorafenib—BRAF—vagina—gestational diabetes	0.00285	0.0132	CbGeAlD
Regorafenib—EPHX2—vagina—gestational diabetes	0.00272	0.0126	CbGeAlD
Regorafenib—PDGFRB—islet of Langerhans—gestational diabetes	0.00263	0.0122	CbGeAlD
Regorafenib—KIT—embryo—gestational diabetes	0.00261	0.0121	CbGeAlD
Regorafenib—PDGFRB—embryo—gestational diabetes	0.00254	0.0118	CbGeAlD
Regorafenib—FGFR2—uterus—gestational diabetes	0.00253	0.0118	CbGeAlD
Regorafenib—FGFR2—adipose tissue—gestational diabetes	0.00247	0.0115	CbGeAlD
Regorafenib—EPHA2—adipose tissue—gestational diabetes	0.00243	0.0113	CbGeAlD
Regorafenib—TEK—uterus—gestational diabetes	0.00243	0.0113	CbGeAlD
Regorafenib—FGFR1—vagina—gestational diabetes	0.00242	0.0112	CbGeAlD
Regorafenib—TEK—adipose tissue—gestational diabetes	0.00237	0.011	CbGeAlD
Regorafenib—ABL1—islet of Langerhans—gestational diabetes	0.00235	0.0109	CbGeAlD
Regorafenib—FLT1—uterus—gestational diabetes	0.00235	0.0109	CbGeAlD
Regorafenib—RAF1—uterus—gestational diabetes	0.00233	0.0108	CbGeAlD
Regorafenib—FLT1—adipose tissue—gestational diabetes	0.00229	0.0107	CbGeAlD
Regorafenib—RAF1—adipose tissue—gestational diabetes	0.00228	0.0106	CbGeAlD
Regorafenib—ABL1—embryo—gestational diabetes	0.00227	0.0105	CbGeAlD
Regorafenib—FLT4—head—gestational diabetes	0.00227	0.0105	CbGeAlD
Regorafenib—PDGFRA—uterus—gestational diabetes	0.0022	0.0102	CbGeAlD
Regorafenib—PDGFRA—adipose tissue—gestational diabetes	0.00215	0.00999	CbGeAlD
Regorafenib—EPHA2—vagina—gestational diabetes	0.00202	0.0094	CbGeAlD
Regorafenib—RET—head—gestational diabetes	0.002	0.0093	CbGeAlD
Regorafenib—KDR—uterus—gestational diabetes	0.00198	0.00922	CbGeAlD
Regorafenib—KDR—adipose tissue—gestational diabetes	0.00194	0.00902	CbGeAlD
Regorafenib—FLT1—vagina—gestational diabetes	0.00191	0.00887	CbGeAlD
Regorafenib—FGFR2—head—gestational diabetes	0.0019	0.00884	CbGeAlD
Regorafenib—RAF1—vagina—gestational diabetes	0.0019	0.00881	CbGeAlD
Regorafenib—EPHA2—head—gestational diabetes	0.00187	0.00868	CbGeAlD
Regorafenib—TEK—head—gestational diabetes	0.00182	0.00847	CbGeAlD
Regorafenib—PDGFRA—vagina—gestational diabetes	0.00179	0.00831	CbGeAlD
Regorafenib—FLT1—head—gestational diabetes	0.00176	0.00819	CbGeAlD
Regorafenib—KIT—uterus—gestational diabetes	0.00176	0.00817	CbGeAlD
Regorafenib—RAF1—head—gestational diabetes	0.00175	0.00814	CbGeAlD
Regorafenib—KIT—adipose tissue—gestational diabetes	0.00172	0.00799	CbGeAlD
Regorafenib—PDGFRB—uterus—gestational diabetes	0.00172	0.00798	CbGeAlD
Regorafenib—PDGFRB—adipose tissue—gestational diabetes	0.00168	0.0078	CbGeAlD
Regorafenib—PDGFRA—head—gestational diabetes	0.00165	0.00767	CbGeAlD
Regorafenib—KDR—vagina—gestational diabetes	0.00161	0.0075	CbGeAlD
Regorafenib—ABL1—uterus—gestational diabetes	0.00153	0.00711	CbGeAlD
Regorafenib—ABL1—adipose tissue—gestational diabetes	0.0015	0.00696	CbGeAlD
Regorafenib—KDR—head—gestational diabetes	0.00149	0.00692	CbGeAlD
Regorafenib—KIT—vagina—gestational diabetes	0.00143	0.00664	CbGeAlD
Regorafenib—PDGFRB—vagina—gestational diabetes	0.0014	0.00649	CbGeAlD
Regorafenib—KIT—head—gestational diabetes	0.00132	0.00614	CbGeAlD
Regorafenib—PDGFRB—head—gestational diabetes	0.00129	0.00599	CbGeAlD
Regorafenib—ABL1—vagina—gestational diabetes	0.00124	0.00578	CbGeAlD
Regorafenib—ABL1—head—gestational diabetes	0.00115	0.00534	CbGeAlD
Regorafenib—ABCG2—uterus—gestational diabetes	0.000965	0.00448	CbGeAlD
Regorafenib—ABCG2—adipose tissue—gestational diabetes	0.000943	0.00439	CbGeAlD
Regorafenib—CYP2C19—vagina—gestational diabetes	0.000924	0.0043	CbGeAlD
Regorafenib—CYP2C8—vagina—gestational diabetes	0.000807	0.00375	CbGeAlD
Regorafenib—ABCG2—vagina—gestational diabetes	0.000784	0.00365	CbGeAlD
Regorafenib—ABCB1—islet of Langerhans—gestational diabetes	0.000729	0.00339	CbGeAlD
Regorafenib—CYP2B6—vagina—gestational diabetes	0.000723	0.00336	CbGeAlD
Regorafenib—ABCB1—embryo—gestational diabetes	0.000705	0.00328	CbGeAlD
Regorafenib—CYP2B6—head—gestational diabetes	0.000668	0.00311	CbGeAlD
Regorafenib—ABCB1—uterus—gestational diabetes	0.000476	0.00221	CbGeAlD
Regorafenib—ABCB1—adipose tissue—gestational diabetes	0.000465	0.00216	CbGeAlD
Regorafenib—ABCB1—vagina—gestational diabetes	0.000387	0.0018	CbGeAlD
Regorafenib—ABCB1—head—gestational diabetes	0.000357	0.00166	CbGeAlD
Regorafenib—RAF1—Downstream signaling of activated FGFR—FGF2—gestational diabetes	0.00022	0.00114	CbGpPWpGaD
Regorafenib—RAF1—Regulation of Actin Cytoskeleton—FGF2—gestational diabetes	0.00022	0.00114	CbGpPWpGaD
Regorafenib—EPHX2—Metabolism—CYP19A1—gestational diabetes	0.00022	0.00114	CbGpPWpGaD
Regorafenib—NTRK1—MAPK Signaling Pathway—TNF—gestational diabetes	0.000219	0.00113	CbGpPWpGaD
Regorafenib—RAF1—Developmental Biology—GCK—gestational diabetes	0.000217	0.00113	CbGpPWpGaD
Regorafenib—RAF1—Signaling by ERBB4—FGF2—gestational diabetes	0.000217	0.00112	CbGpPWpGaD
Regorafenib—PDGFRB—DAP12 interactions—FGF2—gestational diabetes	0.000215	0.00112	CbGpPWpGaD
Regorafenib—PDGFRB—Fc epsilon receptor (FCERI) signaling—FGF2—gestational diabetes	0.000215	0.00112	CbGpPWpGaD
Regorafenib—PDGFRB—Signaling by FGFR in disease—FGF2—gestational diabetes	0.000215	0.00112	CbGpPWpGaD
Regorafenib—RAF1—Innate Immune System—MBL2—gestational diabetes	0.000214	0.00111	CbGpPWpGaD
Regorafenib—PDGFRB—Signaling by EGFR—FGF2—gestational diabetes	0.000213	0.00111	CbGpPWpGaD
Regorafenib—FGFR1—NGF signalling via TRKA from the plasma membrane—FGF2—gestational diabetes	0.000212	0.0011	CbGpPWpGaD
Regorafenib—FLT1—Signaling Pathways—MTNR1B—gestational diabetes	0.000212	0.0011	CbGpPWpGaD
Regorafenib—RAF1—MicroRNAs in cardiomyocyte hypertrophy—TNF—gestational diabetes	0.000212	0.0011	CbGpPWpGaD
Regorafenib—PDGFRA—NGF signalling via TRKA from the plasma membrane—FGF2—gestational diabetes	0.000212	0.0011	CbGpPWpGaD
Regorafenib—PDGFRB—Signaling by EGFR in Cancer—FGF2—gestational diabetes	0.000212	0.0011	CbGpPWpGaD
Regorafenib—PDGFRB—Signaling by PDGF—FGF2—gestational diabetes	0.000211	0.00109	CbGpPWpGaD
Regorafenib—RAF1—Downstream signal transduction—FGF2—gestational diabetes	0.000207	0.00107	CbGpPWpGaD
Regorafenib—MAPK11—Regulation of toll-like receptor signaling pathway—TNF—gestational diabetes	0.000207	0.00107	CbGpPWpGaD
Regorafenib—FLT1—Signaling Pathways—RBP4—gestational diabetes	0.000207	0.00107	CbGpPWpGaD
Regorafenib—RAF1—Signaling by FGFR—FGF2—gestational diabetes	0.000206	0.00107	CbGpPWpGaD
Regorafenib—RAF1—Signaling by ERBB2—FGF2—gestational diabetes	0.000205	0.00106	CbGpPWpGaD
Regorafenib—RAF1—DAP12 signaling—FGF2—gestational diabetes	0.000204	0.00106	CbGpPWpGaD
Regorafenib—EPHA2—Developmental Biology—FGF2—gestational diabetes	0.000203	0.00105	CbGpPWpGaD
Regorafenib—CYP3A4—Phase 1 - Functionalization of compounds—CYP19A1—gestational diabetes	0.000202	0.00105	CbGpPWpGaD
Regorafenib—CYP2C8—Biological oxidations—CYP19A1—gestational diabetes	0.0002	0.00104	CbGpPWpGaD
Regorafenib—PDGFRB—B Cell Activation—FGF2—gestational diabetes	0.000199	0.00103	CbGpPWpGaD
Regorafenib—NTRK1—Integrated Pancreatic Cancer Pathway—TNF—gestational diabetes	0.000198	0.00102	CbGpPWpGaD
Regorafenib—ABL1—Integrated Pancreatic Cancer Pathway—FGF2—gestational diabetes	0.000198	0.00102	CbGpPWpGaD
Regorafenib—CYP2C8—Metapathway biotransformation—CYP19A1—gestational diabetes	0.000197	0.00102	CbGpPWpGaD
Regorafenib—RAF1—TNF alpha Signaling Pathway—TNF—gestational diabetes	0.000197	0.00102	CbGpPWpGaD
Regorafenib—ABL1—Developmental Biology—ADIPOQ—gestational diabetes	0.000196	0.00101	CbGpPWpGaD
Regorafenib—RAF1—Fc epsilon receptor (FCERI) signaling—FGF2—gestational diabetes	0.000192	0.000994	CbGpPWpGaD
Regorafenib—RAF1—DAP12 interactions—FGF2—gestational diabetes	0.000192	0.000994	CbGpPWpGaD
Regorafenib—RAF1—Signaling by FGFR in disease—FGF2—gestational diabetes	0.000192	0.000994	CbGpPWpGaD
Regorafenib—MAPK11—Signaling by NGF—FGF2—gestational diabetes	0.000191	0.000988	CbGpPWpGaD
Regorafenib—PDGFRB—NGF signalling via TRKA from the plasma membrane—FGF2—gestational diabetes	0.000191	0.000988	CbGpPWpGaD
Regorafenib—RAF1—Signaling by EGFR—FGF2—gestational diabetes	0.00019	0.000985	CbGpPWpGaD
Regorafenib—NTRK1—Signaling Pathways—LEPR—gestational diabetes	0.000189	0.000979	CbGpPWpGaD
Regorafenib—BRAF—Signaling by NGF—FGF2—gestational diabetes	0.000189	0.000979	CbGpPWpGaD
Regorafenib—KDR—Developmental Biology—LEP—gestational diabetes	0.000189	0.000977	CbGpPWpGaD
Regorafenib—RAF1—Signaling by EGFR in Cancer—FGF2—gestational diabetes	0.000189	0.000976	CbGpPWpGaD
Regorafenib—RAF1—Signaling by PDGF—FGF2—gestational diabetes	0.000188	0.000972	CbGpPWpGaD
Regorafenib—UGT1A1—Metabolism—GGCT—gestational diabetes	0.000187	0.000967	CbGpPWpGaD
Regorafenib—UGT1A9—Metabolism—GGCT—gestational diabetes	0.000187	0.000967	CbGpPWpGaD
Regorafenib—RAF1—Transmembrane transport of small molecules—GCK—gestational diabetes	0.000185	0.000956	CbGpPWpGaD
Regorafenib—MAPK11—Immune System—MBL2—gestational diabetes	0.000182	0.00094	CbGpPWpGaD
Regorafenib—RAF1—Integrated Pancreatic Cancer Pathway—FGF2—gestational diabetes	0.000181	0.000935	CbGpPWpGaD
Regorafenib—RAF1—Developmental Biology—ADIPOQ—gestational diabetes	0.000179	0.000927	CbGpPWpGaD
Regorafenib—KDR—Signaling Pathways—LEPR—gestational diabetes	0.000179	0.000925	CbGpPWpGaD
Regorafenib—CYP2C19—Biological oxidations—CYP19A1—gestational diabetes	0.000179	0.000925	CbGpPWpGaD
Regorafenib—BRAF—MAPK Signaling Pathway—TNF—gestational diabetes	0.000176	0.000912	CbGpPWpGaD
Regorafenib—CYP2C19—Metapathway biotransformation—CYP19A1—gestational diabetes	0.000176	0.000912	CbGpPWpGaD
Regorafenib—FGFR2—Signaling by NGF—FGF2—gestational diabetes	0.000175	0.000907	CbGpPWpGaD
Regorafenib—KIT—Signaling by NGF—FGF2—gestational diabetes	0.000172	0.000891	CbGpPWpGaD
Regorafenib—RAF1—NGF signalling via TRKA from the plasma membrane—FGF2—gestational diabetes	0.00017	0.00088	CbGpPWpGaD
Regorafenib—BRAF—Disease—RBP4—gestational diabetes	0.000167	0.000867	CbGpPWpGaD
Regorafenib—FGFR2—Immune System—MBL2—gestational diabetes	0.000167	0.000863	CbGpPWpGaD
Regorafenib—KIT—Immune System—MBL2—gestational diabetes	0.000164	0.000847	CbGpPWpGaD
Regorafenib—FGFR1—Signaling by NGF—FGF2—gestational diabetes	0.000163	0.000845	CbGpPWpGaD
Regorafenib—UGT1A9—Metabolism—GLS2—gestational diabetes	0.000163	0.000845	CbGpPWpGaD
Regorafenib—UGT1A1—Metabolism—GLS2—gestational diabetes	0.000163	0.000845	CbGpPWpGaD
Regorafenib—PDGFRA—Signaling by NGF—FGF2—gestational diabetes	0.000163	0.000843	CbGpPWpGaD
Regorafenib—CYP2C9—Biological oxidations—CYP19A1—gestational diabetes	0.000163	0.000843	CbGpPWpGaD
Regorafenib—MAPK11—Developmental Biology—LEP—gestational diabetes	0.000162	0.00084	CbGpPWpGaD
Regorafenib—ABCG2—Transmembrane transport of small molecules—GCK—gestational diabetes	0.000161	0.000834	CbGpPWpGaD
Regorafenib—CYP2C9—Metapathway biotransformation—CYP19A1—gestational diabetes	0.000161	0.000831	CbGpPWpGaD
Regorafenib—ABCG2—Metabolism—GGCT—gestational diabetes	0.000158	0.00082	CbGpPWpGaD
Regorafenib—ABCB1—Integrated Pancreatic Cancer Pathway—AR—gestational diabetes	0.000156	0.000807	CbGpPWpGaD
Regorafenib—FGFR1—Immune System—MBL2—gestational diabetes	0.000155	0.000804	CbGpPWpGaD
Regorafenib—FGFR2—Disease—RBP4—gestational diabetes	0.000155	0.000803	CbGpPWpGaD
Regorafenib—PDGFRA—Immune System—MBL2—gestational diabetes	0.000155	0.000802	CbGpPWpGaD
Regorafenib—MAPK11—Signaling Pathways—LEPR—gestational diabetes	0.000154	0.000795	CbGpPWpGaD
Regorafenib—KIT—Disease—RBP4—gestational diabetes	0.000152	0.000789	CbGpPWpGaD
Regorafenib—FGFR1—MAPK Signaling Pathway—TNF—gestational diabetes	0.000152	0.000788	CbGpPWpGaD
Regorafenib—BRAF—Signaling Pathways—LEPR—gestational diabetes	0.000152	0.000788	CbGpPWpGaD
Regorafenib—BRAF—Disease—NAMPT—gestational diabetes	0.00015	0.000777	CbGpPWpGaD
Regorafenib—NTRK1—Signaling Pathways—MTNR1B—gestational diabetes	0.000149	0.000774	CbGpPWpGaD
Regorafenib—BRAF—Disease—GCK—gestational diabetes	0.000149	0.000773	CbGpPWpGaD
Regorafenib—PDGFRB—Signaling by NGF—FGF2—gestational diabetes	0.000147	0.00076	CbGpPWpGaD
Regorafenib—UGT1A9—Metabolism of lipids and lipoproteins—CYP19A1—gestational diabetes	0.000146	0.000755	CbGpPWpGaD
Regorafenib—NTRK1—Signaling Pathways—RBP4—gestational diabetes	0.000146	0.000754	CbGpPWpGaD
Regorafenib—FGFR1—Disease—RBP4—gestational diabetes	0.000145	0.000749	CbGpPWpGaD
Regorafenib—PDGFRA—Disease—RBP4—gestational diabetes	0.000144	0.000747	CbGpPWpGaD
Regorafenib—KDR—Developmental Biology—FGF2—gestational diabetes	0.000143	0.000742	CbGpPWpGaD
Regorafenib—KDR—Signaling Pathways—MTNR1B—gestational diabetes	0.000141	0.000731	CbGpPWpGaD
Regorafenib—FGFR2—Signaling Pathways—LEPR—gestational diabetes	0.000141	0.00073	CbGpPWpGaD
Regorafenib—RAF1—Signaling by GPCR—MTNR1B—gestational diabetes	0.000141	0.000729	CbGpPWpGaD
Regorafenib—PDGFRB—Immune System—MBL2—gestational diabetes	0.00014	0.000723	CbGpPWpGaD
Regorafenib—FGFR2—Disease—NAMPT—gestational diabetes	0.000139	0.00072	CbGpPWpGaD
Regorafenib—FGFR1—Developmental Biology—LEP—gestational diabetes	0.000139	0.000719	CbGpPWpGaD
Regorafenib—KIT—Signaling Pathways—LEPR—gestational diabetes	0.000139	0.000717	CbGpPWpGaD
Regorafenib—ABCG2—Metabolism—GLS2—gestational diabetes	0.000138	0.000717	CbGpPWpGaD
Regorafenib—FGFR2—Disease—GCK—gestational diabetes	0.000138	0.000716	CbGpPWpGaD
Regorafenib—KDR—Signaling Pathways—RBP4—gestational diabetes	0.000138	0.000712	CbGpPWpGaD
Regorafenib—FGFR1—Integrated Pancreatic Cancer Pathway—TNF—gestational diabetes	0.000137	0.000711	CbGpPWpGaD
Regorafenib—PDGFRA—Integrated Pancreatic Cancer Pathway—TNF—gestational diabetes	0.000137	0.000709	CbGpPWpGaD
Regorafenib—PDGFRB—MAPK Signaling Pathway—TNF—gestational diabetes	0.000137	0.000708	CbGpPWpGaD
Regorafenib—KIT—Disease—NAMPT—gestational diabetes	0.000137	0.000708	CbGpPWpGaD
Regorafenib—ABL1—Immune System—MBL2—gestational diabetes	0.000136	0.000704	CbGpPWpGaD
Regorafenib—KIT—Disease—GCK—gestational diabetes	0.000136	0.000703	CbGpPWpGaD
Regorafenib—FGFR1—Signaling Pathways—LEPR—gestational diabetes	0.000131	0.000681	CbGpPWpGaD
Regorafenib—PDGFRA—Signaling Pathways—LEPR—gestational diabetes	0.000131	0.000679	CbGpPWpGaD
Regorafenib—RAF1—Signaling by NGF—FGF2—gestational diabetes	0.000131	0.000677	CbGpPWpGaD
Regorafenib—PDGFRB—Disease—RBP4—gestational diabetes	0.00013	0.000673	CbGpPWpGaD
Regorafenib—FGFR1—Disease—NAMPT—gestational diabetes	0.00013	0.000672	CbGpPWpGaD
Regorafenib—PDGFRA—Disease—NAMPT—gestational diabetes	0.000129	0.00067	CbGpPWpGaD
Regorafenib—FGFR1—Disease—GCK—gestational diabetes	0.000129	0.000667	CbGpPWpGaD
Regorafenib—PDGFRA—Disease—GCK—gestational diabetes	0.000129	0.000666	CbGpPWpGaD
Regorafenib—FLT4—Signaling Pathways—LEP—gestational diabetes	0.000126	0.000654	CbGpPWpGaD
Regorafenib—RAF1—Immune System—MBL2—gestational diabetes	0.000124	0.000644	CbGpPWpGaD
Regorafenib—EPHA2—Developmental Biology—TNF—gestational diabetes	0.000124	0.000641	CbGpPWpGaD
Regorafenib—MAPK11—Developmental Biology—FGF2—gestational diabetes	0.000123	0.000638	CbGpPWpGaD
Regorafenib—RAF1—MAPK Signaling Pathway—TNF—gestational diabetes	0.000122	0.000631	CbGpPWpGaD
Regorafenib—ABL1—Developmental Biology—LEP—gestational diabetes	0.000122	0.000629	CbGpPWpGaD
Regorafenib—MAPK11—Signaling Pathways—MTNR1B—gestational diabetes	0.000121	0.000629	CbGpPWpGaD
Regorafenib—BRAF—Signaling Pathways—MTNR1B—gestational diabetes	0.00012	0.000623	CbGpPWpGaD
Regorafenib—ABL1—Integrated Pancreatic Cancer Pathway—TNF—gestational diabetes	0.00012	0.000623	CbGpPWpGaD
Regorafenib—MAPK11—Signaling Pathways—RBP4—gestational diabetes	0.000118	0.000613	CbGpPWpGaD
Regorafenib—PDGFRB—Signaling Pathways—LEPR—gestational diabetes	0.000118	0.000612	CbGpPWpGaD
Regorafenib—BRAF—Signaling Pathways—RBP4—gestational diabetes	0.000117	0.000607	CbGpPWpGaD
Regorafenib—PDGFRB—Disease—NAMPT—gestational diabetes	0.000117	0.000603	CbGpPWpGaD
Regorafenib—CYP2B6—Metabolism—GGCT—gestational diabetes	0.000116	0.000601	CbGpPWpGaD
Regorafenib—RAF1—Disease—RBP4—gestational diabetes	0.000116	0.0006	CbGpPWpGaD
Regorafenib—PDGFRB—Disease—GCK—gestational diabetes	0.000116	0.0006	CbGpPWpGaD
Regorafenib—MAPK11—Gene Expression—AR—gestational diabetes	0.000115	0.000597	CbGpPWpGaD
Regorafenib—FGFR2—Signaling Pathways—MTNR1B—gestational diabetes	0.000111	0.000577	CbGpPWpGaD
Regorafenib—RAF1—Developmental Biology—LEP—gestational diabetes	0.000111	0.000576	CbGpPWpGaD
Regorafenib—RAF1—Integrated Pancreatic Cancer Pathway—TNF—gestational diabetes	0.00011	0.00057	CbGpPWpGaD
Regorafenib—KIT—Signaling Pathways—MTNR1B—gestational diabetes	0.000109	0.000567	CbGpPWpGaD
Regorafenib—MAPK11—Innate Immune System—FGF2—gestational diabetes	0.000109	0.000563	CbGpPWpGaD
Regorafenib—FGFR2—Signaling Pathways—RBP4—gestational diabetes	0.000109	0.000563	CbGpPWpGaD
Regorafenib—CYP3A4—Biological oxidations—CYP19A1—gestational diabetes	0.000107	0.000556	CbGpPWpGaD
Regorafenib—KIT—Signaling Pathways—RBP4—gestational diabetes	0.000107	0.000552	CbGpPWpGaD
Regorafenib—CYP3A4—Metapathway biotransformation—CYP19A1—gestational diabetes	0.000106	0.000548	CbGpPWpGaD
Regorafenib—FGFR1—Developmental Biology—FGF2—gestational diabetes	0.000105	0.000546	CbGpPWpGaD
Regorafenib—RAF1—Signaling Pathways—LEPR—gestational diabetes	0.000105	0.000545	CbGpPWpGaD
Regorafenib—ABCB1—Allograft Rejection—TNF—gestational diabetes	0.000105	0.000544	CbGpPWpGaD
Regorafenib—FGFR1—Signaling Pathways—MTNR1B—gestational diabetes	0.000104	0.000538	CbGpPWpGaD
Regorafenib—RAF1—Disease—NAMPT—gestational diabetes	0.000104	0.000538	CbGpPWpGaD
Regorafenib—PDGFRA—Signaling Pathways—MTNR1B—gestational diabetes	0.000104	0.000537	CbGpPWpGaD
Regorafenib—RAF1—Disease—GCK—gestational diabetes	0.000103	0.000534	CbGpPWpGaD
Regorafenib—CYP2B6—Metabolism—GLS2—gestational diabetes	0.000102	0.000526	CbGpPWpGaD
Regorafenib—FGFR1—Signaling Pathways—RBP4—gestational diabetes	0.000101	0.000524	CbGpPWpGaD
Regorafenib—PDGFRA—Signaling Pathways—RBP4—gestational diabetes	0.000101	0.000523	CbGpPWpGaD
Regorafenib—FGFR2—Innate Immune System—FGF2—gestational diabetes	9.99e-05	0.000517	CbGpPWpGaD
Regorafenib—CYP2C8—Metabolism—GGCT—gestational diabetes	9.83e-05	0.000509	CbGpPWpGaD
Regorafenib—KIT—Innate Immune System—FGF2—gestational diabetes	9.81e-05	0.000508	CbGpPWpGaD
Regorafenib—FLT4—Signaling Pathways—FGF2—gestational diabetes	9.6e-05	0.000497	CbGpPWpGaD
Regorafenib—FGFR2—Adaptive Immune System—FGF2—gestational diabetes	9.6e-05	0.000497	CbGpPWpGaD
Regorafenib—FLT1—Signaling Pathways—LEP—gestational diabetes	9.43e-05	0.000488	CbGpPWpGaD
Regorafenib—KIT—Adaptive Immune System—FGF2—gestational diabetes	9.42e-05	0.000488	CbGpPWpGaD
Regorafenib—PDGFRB—Signaling Pathways—MTNR1B—gestational diabetes	9.34e-05	0.000483	CbGpPWpGaD
Regorafenib—FGFR1—Innate Immune System—FGF2—gestational diabetes	9.31e-05	0.000482	CbGpPWpGaD
Regorafenib—PDGFRA—Innate Immune System—FGF2—gestational diabetes	9.29e-05	0.000481	CbGpPWpGaD
Regorafenib—ABL1—Developmental Biology—FGF2—gestational diabetes	9.23e-05	0.000478	CbGpPWpGaD
Regorafenib—PDGFRB—Signaling Pathways—RBP4—gestational diabetes	9.1e-05	0.000471	CbGpPWpGaD
Regorafenib—UGT1A1—Metabolism—NAMPT—gestational diabetes	8.94e-05	0.000463	CbGpPWpGaD
Regorafenib—UGT1A9—Metabolism—NAMPT—gestational diabetes	8.94e-05	0.000463	CbGpPWpGaD
Regorafenib—FGFR1—Adaptive Immune System—FGF2—gestational diabetes	8.94e-05	0.000463	CbGpPWpGaD
Regorafenib—PDGFRA—Adaptive Immune System—FGF2—gestational diabetes	8.92e-05	0.000462	CbGpPWpGaD
Regorafenib—UGT1A1—Metabolism—GCK—gestational diabetes	8.89e-05	0.00046	CbGpPWpGaD
Regorafenib—UGT1A9—Metabolism—GCK—gestational diabetes	8.89e-05	0.00046	CbGpPWpGaD
Regorafenib—CYP2C19—Metabolism—GGCT—gestational diabetes	8.78e-05	0.000454	CbGpPWpGaD
Regorafenib—KDR—Developmental Biology—TNF—gestational diabetes	8.73e-05	0.000452	CbGpPWpGaD
Regorafenib—ABCB1—Transmembrane transport of small molecules—GCK—gestational diabetes	8.7e-05	0.000451	CbGpPWpGaD
Regorafenib—CYP2C8—Metabolism—GLS2—gestational diabetes	8.59e-05	0.000445	CbGpPWpGaD
Regorafenib—ABCB1—Metabolism—GGCT—gestational diabetes	8.57e-05	0.000444	CbGpPWpGaD
Regorafenib—ABCB1—Integrated Pancreatic Cancer Pathway—FGF2—gestational diabetes	8.52e-05	0.000441	CbGpPWpGaD
Regorafenib—RAF1—Developmental Biology—FGF2—gestational diabetes	8.45e-05	0.000437	CbGpPWpGaD
Regorafenib—PDGFRB—Innate Immune System—FGF2—gestational diabetes	8.37e-05	0.000433	CbGpPWpGaD
Regorafenib—RAF1—Signaling Pathways—MTNR1B—gestational diabetes	8.32e-05	0.000431	CbGpPWpGaD
Regorafenib—ABL1—Innate Immune System—FGF2—gestational diabetes	8.16e-05	0.000422	CbGpPWpGaD
Regorafenib—RAF1—Signaling Pathways—RBP4—gestational diabetes	8.11e-05	0.00042	CbGpPWpGaD
Regorafenib—PDGFRB—Adaptive Immune System—FGF2—gestational diabetes	8.04e-05	0.000416	CbGpPWpGaD
Regorafenib—CYP2C9—Metabolism—GGCT—gestational diabetes	8e-05	0.000414	CbGpPWpGaD
Regorafenib—CYP2C8—Metabolism of lipids and lipoproteins—CYP19A1—gestational diabetes	7.68e-05	0.000398	CbGpPWpGaD
Regorafenib—CYP2C19—Metabolism—GLS2—gestational diabetes	7.67e-05	0.000397	CbGpPWpGaD
Regorafenib—ABCG2—Metabolism—NAMPT—gestational diabetes	7.59e-05	0.000393	CbGpPWpGaD
Regorafenib—ABCG2—Metabolism—GCK—gestational diabetes	7.54e-05	0.00039	CbGpPWpGaD
Regorafenib—MAPK11—Developmental Biology—TNF—gestational diabetes	7.5e-05	0.000389	CbGpPWpGaD
Regorafenib—ABCB1—Metabolism—GLS2—gestational diabetes	7.49e-05	0.000388	CbGpPWpGaD
Regorafenib—RAF1—Innate Immune System—FGF2—gestational diabetes	7.46e-05	0.000386	CbGpPWpGaD
Regorafenib—FLT1—Signaling Pathways—FGF2—gestational diabetes	7.16e-05	0.000371	CbGpPWpGaD
Regorafenib—RAF1—Adaptive Immune System—FGF2—gestational diabetes	7.16e-05	0.000371	CbGpPWpGaD
Regorafenib—CYP2C9—Metabolism—GLS2—gestational diabetes	7e-05	0.000362	CbGpPWpGaD
Regorafenib—CYP2C19—Metabolism of lipids and lipoproteins—CYP19A1—gestational diabetes	6.86e-05	0.000355	CbGpPWpGaD
Regorafenib—NTRK1—Signaling Pathways—LEP—gestational diabetes	6.64e-05	0.000344	CbGpPWpGaD
Regorafenib—UGT1A9—Metabolism—CYP19A1—gestational diabetes	6.5e-05	0.000336	CbGpPWpGaD
Regorafenib—UGT1A1—Metabolism—CYP19A1—gestational diabetes	6.5e-05	0.000336	CbGpPWpGaD
Regorafenib—FGFR1—Developmental Biology—TNF—gestational diabetes	6.42e-05	0.000332	CbGpPWpGaD
Regorafenib—MAPK11—Immune System—FGF2—gestational diabetes	6.34e-05	0.000328	CbGpPWpGaD
Regorafenib—KDR—Signaling Pathways—LEP—gestational diabetes	6.27e-05	0.000325	CbGpPWpGaD
Regorafenib—CYP2C9—Metabolism of lipids and lipoproteins—CYP19A1—gestational diabetes	6.25e-05	0.000324	CbGpPWpGaD
Regorafenib—FGFR2—Immune System—FGF2—gestational diabetes	5.82e-05	0.000301	CbGpPWpGaD
Regorafenib—BRAF—Disease—FGF2—gestational diabetes	5.8e-05	0.0003	CbGpPWpGaD
Regorafenib—KIT—Immune System—FGF2—gestational diabetes	5.72e-05	0.000296	CbGpPWpGaD
Regorafenib—ABL1—Developmental Biology—TNF—gestational diabetes	5.62e-05	0.000291	CbGpPWpGaD
Regorafenib—CYP2B6—Metabolism—NAMPT—gestational diabetes	5.56e-05	0.000288	CbGpPWpGaD
Regorafenib—CYP2B6—Metabolism—GCK—gestational diabetes	5.53e-05	0.000286	CbGpPWpGaD
Regorafenib—ABCG2—Metabolism—CYP19A1—gestational diabetes	5.51e-05	0.000285	CbGpPWpGaD
Regorafenib—FGFR1—Immune System—FGF2—gestational diabetes	5.42e-05	0.000281	CbGpPWpGaD
Regorafenib—PDGFRA—Immune System—FGF2—gestational diabetes	5.41e-05	0.00028	CbGpPWpGaD
Regorafenib—MAPK11—Signaling Pathways—LEP—gestational diabetes	5.4e-05	0.000279	CbGpPWpGaD
Regorafenib—FGFR2—Disease—FGF2—gestational diabetes	5.37e-05	0.000278	CbGpPWpGaD
Regorafenib—BRAF—Signaling Pathways—LEP—gestational diabetes	5.34e-05	0.000277	CbGpPWpGaD
Regorafenib—CYP3A4—Metabolism—GGCT—gestational diabetes	5.28e-05	0.000273	CbGpPWpGaD
Regorafenib—KIT—Disease—FGF2—gestational diabetes	5.28e-05	0.000273	CbGpPWpGaD
Regorafenib—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—gestational diabetes	5.19e-05	0.000269	CbGpPWpGaD
Regorafenib—RAF1—Developmental Biology—TNF—gestational diabetes	5.14e-05	0.000266	CbGpPWpGaD
Regorafenib—NTRK1—Signaling Pathways—FGF2—gestational diabetes	5.04e-05	0.000261	CbGpPWpGaD
Regorafenib—FGFR1—Disease—FGF2—gestational diabetes	5.01e-05	0.000259	CbGpPWpGaD
Regorafenib—PDGFRA—Disease—FGF2—gestational diabetes	5e-05	0.000259	CbGpPWpGaD
Regorafenib—FGFR2—Signaling Pathways—LEP—gestational diabetes	4.95e-05	0.000256	CbGpPWpGaD
Regorafenib—PDGFRB—Immune System—FGF2—gestational diabetes	4.87e-05	0.000252	CbGpPWpGaD
Regorafenib—KIT—Signaling Pathways—LEP—gestational diabetes	4.86e-05	0.000252	CbGpPWpGaD
Regorafenib—KDR—Signaling Pathways—FGF2—gestational diabetes	4.77e-05	0.000247	CbGpPWpGaD
Regorafenib—ABL1—Immune System—FGF2—gestational diabetes	4.75e-05	0.000246	CbGpPWpGaD
Regorafenib—CYP2C8—Metabolism—NAMPT—gestational diabetes	4.71e-05	0.000244	CbGpPWpGaD
Regorafenib—CYP2C8—Metabolism—GCK—gestational diabetes	4.68e-05	0.000242	CbGpPWpGaD
Regorafenib—FGFR1—Signaling Pathways—LEP—gestational diabetes	4.62e-05	0.000239	CbGpPWpGaD
Regorafenib—CYP3A4—Metabolism—GLS2—gestational diabetes	4.61e-05	0.000239	CbGpPWpGaD
Regorafenib—PDGFRA—Signaling Pathways—LEP—gestational diabetes	4.61e-05	0.000238	CbGpPWpGaD
Regorafenib—PDGFRB—Disease—FGF2—gestational diabetes	4.5e-05	0.000233	CbGpPWpGaD
Regorafenib—RAF1—Immune System—FGF2—gestational diabetes	4.34e-05	0.000225	CbGpPWpGaD
Regorafenib—CYP2C19—Metabolism—NAMPT—gestational diabetes	4.2e-05	0.000218	CbGpPWpGaD
Regorafenib—CYP2C19—Metabolism—GCK—gestational diabetes	4.18e-05	0.000216	CbGpPWpGaD
Regorafenib—PDGFRB—Signaling Pathways—LEP—gestational diabetes	4.15e-05	0.000215	CbGpPWpGaD
Regorafenib—ABCB1—Metabolism—NAMPT—gestational diabetes	4.1e-05	0.000212	CbGpPWpGaD
Regorafenib—MAPK11—Signaling Pathways—FGF2—gestational diabetes	4.1e-05	0.000212	CbGpPWpGaD
Regorafenib—ABCB1—Metabolism—GCK—gestational diabetes	4.08e-05	0.000211	CbGpPWpGaD
Regorafenib—BRAF—Signaling Pathways—FGF2—gestational diabetes	4.06e-05	0.00021	CbGpPWpGaD
Regorafenib—CYP2B6—Metabolism—CYP19A1—gestational diabetes	4.04e-05	0.000209	CbGpPWpGaD
Regorafenib—RAF1—Disease—FGF2—gestational diabetes	4.01e-05	0.000208	CbGpPWpGaD
Regorafenib—CYP2C9—Metabolism—NAMPT—gestational diabetes	3.83e-05	0.000198	CbGpPWpGaD
Regorafenib—CYP2C9—Metabolism—GCK—gestational diabetes	3.81e-05	0.000197	CbGpPWpGaD
Regorafenib—FGFR2—Signaling Pathways—FGF2—gestational diabetes	3.76e-05	0.000195	CbGpPWpGaD
Regorafenib—RAF1—Signaling Pathways—LEP—gestational diabetes	3.7e-05	0.000191	CbGpPWpGaD
Regorafenib—KIT—Signaling Pathways—FGF2—gestational diabetes	3.7e-05	0.000191	CbGpPWpGaD
Regorafenib—FGFR1—Signaling Pathways—FGF2—gestational diabetes	3.51e-05	0.000182	CbGpPWpGaD
Regorafenib—PDGFRA—Signaling Pathways—FGF2—gestational diabetes	3.5e-05	0.000181	CbGpPWpGaD
Regorafenib—CYP2C8—Metabolism—CYP19A1—gestational diabetes	3.42e-05	0.000177	CbGpPWpGaD
Regorafenib—PDGFRB—Signaling Pathways—FGF2—gestational diabetes	3.15e-05	0.000163	CbGpPWpGaD
Regorafenib—CYP2C19—Metabolism—CYP19A1—gestational diabetes	3.05e-05	0.000158	CbGpPWpGaD
Regorafenib—ABCB1—Metabolism—CYP19A1—gestational diabetes	2.98e-05	0.000154	CbGpPWpGaD
Regorafenib—RAF1—Signaling Pathways—FGF2—gestational diabetes	2.81e-05	0.000145	CbGpPWpGaD
Regorafenib—CYP2C9—Metabolism—CYP19A1—gestational diabetes	2.78e-05	0.000144	CbGpPWpGaD
Regorafenib—CYP3A4—Metabolism—NAMPT—gestational diabetes	2.53e-05	0.000131	CbGpPWpGaD
Regorafenib—CYP3A4—Metabolism—GCK—gestational diabetes	2.51e-05	0.00013	CbGpPWpGaD
Regorafenib—CYP3A4—Metabolism—CYP19A1—gestational diabetes	1.84e-05	9.51e-05	CbGpPWpGaD
